{
  "success": true,
  "pagesUsed": [
    2,
    4,
    10,
    12,
    15,
    17,
    20,
    25,
    27,
    29,
    32,
    37,
    39,
    40,
    41,
    42,
    57
  ],
  "modelUsed": "gemini-2.5-pro",
  "confidence": 1.0,
  "scheduling": {
    "timings": [
      {
        "id": "timing_1",
        "name": "End of Study Visit Window",
        "type": {
          "id": "380cca77-a2dc-440c-b33d-7645b77be36b",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P54D",
        "valueLabel": "Day 54",
        "relativeToFrom": {
          "id": "60376e9f-03fa-487f-bacd-d288f5942ef5",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "720e7f33-8110-4fd3-bd2a-15407b7b7f84",
        "instanceType": "Timing",
        "windowLower": "-P2D",
        "windowUpper": "P2D"
      },
      {
        "id": "timing_2",
        "name": "Zinc Washout Period",
        "type": {
          "id": "709da913-a446-402c-b39f-9fe2c7e2cf58",
          "code": "C71151",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Within",
          "instanceType": "Code"
        },
        "value": "P21D",
        "valueLabel": "Day 21",
        "relativeToFrom": {
          "id": "1a123131-616a-4080-9a58-4f027fae00eb",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "c9c9fe2d-887d-4ff2-8700-b82c2845f8ea",
        "instanceType": "Timing",
        "windowLower": "-P21D",
        "windowUpper": "-P1D"
      },
      {
        "id": "timing_3",
        "name": "Tetrathiomolybdate Washout Period",
        "type": {
          "id": "64deefbd-0b5d-4e51-bada-4243961c0e5c",
          "code": "C71151",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Within",
          "instanceType": "Code"
        },
        "value": "P1D",
        "valueLabel": "1 years",
        "relativeToFrom": {
          "id": "d84394ba-62eb-4dbd-bf2e-7bc7883d8b67",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "d1364bcb-4db8-4895-b6a5-c29aaad00761",
        "instanceType": "Timing",
        "windowLower": "-P365D",
        "windowUpper": "-P1D"
      },
      {
        "id": "timing_4",
        "name": "Experimental Therapy Washout Period",
        "type": {
          "id": "6f1e4381-74d5-4380-94aa-74bc11acfc89",
          "code": "C71151",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Within",
          "instanceType": "Code"
        },
        "value": "P90D",
        "valueLabel": "Day 90",
        "relativeToFrom": {
          "id": "f0710fb6-e799-4ea6-bd6e-7bed8a70d375",
          "code": "C71158",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Screening",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "47411a96-05e7-4ce3-b2d2-7818949add45",
        "instanceType": "Timing",
        "windowLower": "-P90D",
        "windowUpper": "-P1D"
      },
      {
        "id": "timing_5",
        "name": "Prescription Medication Washout",
        "type": {
          "id": "ef007974-48b7-46d8-a207-5522f3b9d6a0",
          "code": "C71151",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Within",
          "instanceType": "Code"
        },
        "value": "P14D",
        "valueLabel": "Day 14",
        "relativeToFrom": {
          "id": "04eca2ed-da99-49a1-bb30-bc787fcd0da3",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "35b1ab38-5af8-4769-acfc-1924c2f90397",
        "instanceType": "Timing",
        "windowLower": "-P14D",
        "windowUpper": "-P1D"
      },
      {
        "id": "timing_6",
        "name": "Non-Prescription Medication Washout",
        "type": {
          "id": "93f6611f-cc05-44ee-928b-6d104019495d",
          "code": "C71151",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Within",
          "instanceType": "Code"
        },
        "value": "P7D",
        "valueLabel": "Day 7",
        "relativeToFrom": {
          "id": "c27fb277-dab5-498f-bf89-4cd3358cd8b5",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "505ad019-5a05-438b-b731-4bdea3053e5b",
        "instanceType": "Timing",
        "windowLower": "-P7D",
        "windowUpper": "-P1D"
      },
      {
        "id": "timing_7",
        "name": "Alcohol Abstinence Prior to Dosing",
        "type": {
          "id": "0d04631b-cbed-4cef-a3fd-c5e622ef8862",
          "code": "C71151",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Within",
          "instanceType": "Code"
        },
        "value": "PT48H",
        "valueLabel": "48 hours",
        "relativeToFrom": {
          "id": "c3bdb569-ba3a-4060-aef1-20d7348f394b",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "06cd0db9-201f-47af-9e76-2070f90151f3",
        "instanceType": "Timing",
        "windowLower": "-PT48H",
        "windowUpper": "PT0H"
      },
      {
        "id": "timing_8",
        "name": "Outpatient Period Extension",
        "type": {
          "id": "49152aad-d98a-4e93-b4d3-69f8ac973533",
          "code": "C71152",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Between",
          "instanceType": "Code"
        },
        "value": "P14D",
        "valueLabel": "Day 14",
        "relativeToFrom": {
          "id": "d85abf56-f72a-496f-ab7e-9cbdd05c062a",
          "code": "C71157",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Previous Visit",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "f17c60b8-a5c5-49bd-97ca-bdce63d85e1a",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P14D"
      },
      {
        "id": "timing_9",
        "name": "Dosing Fasting Requirement",
        "type": {
          "id": "a15b7de4-cbc5-412a-b8d8-19eba4638564",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "PT10H",
        "valueLabel": "10 hours",
        "relativeToFrom": {
          "id": "554f8f28-fbdc-42e9-99f1-a967ea4b56d0",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "2da07d5c-6cec-4021-bbff-61c6de8080ec",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_10",
        "name": "Post-Dose Meal Delay",
        "type": {
          "id": "536cb468-bc9f-48a0-bc31-40cc75c23c1b",
          "code": "C71150",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "After",
          "instanceType": "Code"
        },
        "value": "PT2H",
        "valueLabel": "2 hours",
        "relativeToFrom": {
          "id": "237d4bb2-6262-4a29-a522-db30d5630922",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "4e37e4ad-1f9a-42ff-8893-13b8c4fdd872",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_11",
        "name": "Outpatient Dosing Time Window",
        "type": {
          "id": "30d6d810-be2e-46d6-b1b6-1105e7e7228e",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "PT0H",
        "valueLabel": "0 hours",
        "relativeToFrom": {
          "id": "0fd6769b-7cba-4773-a82e-35385c2734b9",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "e0ac6982-bab7-446c-89f6-9a05b7404e37",
        "instanceType": "Timing",
        "windowLower": "-PT1H",
        "windowUpper": "PT1H"
      },
      {
        "id": "timing_12",
        "name": "Chelator Discontinuation for Baseline",
        "type": {
          "id": "48d7ee81-6d63-4a69-9c5b-819f7535b14f",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P4D",
        "valueLabel": "Day 4",
        "relativeToFrom": {
          "id": "ced2e5ff-3012-4400-b06f-3be15d49032d",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "603e32f2-a543-46a0-88e4-07393c330bfc",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_13",
        "name": "Notification of Clinically Concerning Event",
        "type": {
          "id": "c0ff5438-dcd1-450d-9843-3ad67d114c2d",
          "code": "C71151",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Within",
          "instanceType": "Code"
        },
        "value": "PT24H",
        "valueLabel": "24 hours",
        "relativeToFrom": {
          "id": "724e27c9-b038-47be-9c5c-6db3d09191e5",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "ec772b3c-594e-4364-82a0-80651b54afbb",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      }
    ],
    "conditions": [
      {
        "id": "cond_1",
        "name": "ALT/AST Elevation for Dose Interruption",
        "instanceType": "Condition",
        "description": "Criteria for temporarily interrupting ALXN1840 dosing due to elevated liver transaminases.",
        "text": "ALT and/or AST > 3 × ULN and ≤ 5 × ULN"
      },
      {
        "id": "cond_2",
        "name": "ALT/AST Elevation for Discontinuation",
        "instanceType": "Condition",
        "description": "Criteria for permanently discontinuing ALXN1840 dosing due to elevated liver transaminases.",
        "text": "ALT and/or AST > 5 × ULN"
      },
      {
        "id": "cond_3",
        "name": "Neutropenia for Dose Interruption",
        "instanceType": "Condition",
        "description": "Criteria for temporarily interrupting ALXN1840 dosing due to low neutrophil count.",
        "text": "Neutrophils < 1.0 × 10^9/L"
      },
      {
        "id": "cond_4",
        "name": "Neutrophil Decrease for Dose Reduction",
        "instanceType": "Condition",
        "description": "Criteria for reducing ALXN1840 dose due to a significant decrease in neutrophil count.",
        "text": "> 30% decrease from baseline and Neutrophils below reference range at baseline"
      },
      {
        "id": "cond_5",
        "name": "Potential Liver Injury (Hy's Law)",
        "instanceType": "Condition",
        "description": "Criteria for temporarily interrupting ALXN1840 dosing due to concurrent elevation of bilirubin and ALT.",
        "text": "Bilirubin > 2 × ULN Accompanied by ALT > 3 × ULN, indicative of liver injury"
      },
      {
        "id": "cond_6",
        "name": "Neurologic Worsening",
        "instanceType": "Condition",
        "description": "Clinical evidence of neurologic worsening that triggers an evaluation for dose modification.",
        "text": "Evidence of neurologic worsening by AEs or by neurologic physical exam assessment"
      },
      {
        "id": "cond_7",
        "name": "Psychiatric Worsening",
        "instanceType": "Condition",
        "description": "Clinical evidence of psychiatric worsening that triggers an evaluation for dose modification.",
        "text": "Evidence of clinically significant acute psychiatric worsening which may include but not limited to suicidality, acute depression, or psychosis."
      },
      {
        "id": "cond_8",
        "name": "Safety Review for Dose Titration",
        "instanceType": "Condition",
        "description": "The Safety Review Committee must review safety data before a participant can be titrated to a higher dose.",
        "text": "Before titration to 30 mg/day, the Safety Review Committee (SRC) will review available safety data through Day 23 for each participant."
      },
      {
        "id": "cond_9",
        "name": "Renal Function Eligibility",
        "instanceType": "Condition",
        "description": "Exclusion criterion based on creatinine clearance.",
        "text": "creatinine clearance < 30 mL/min"
      }
    ],
    "conditionAssignments": [],
    "transitionRules": [
      {
        "id": "trans_1",
        "name": "Dose Titration to 30mg",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "fromElementId": "dose_15mg",
        "toElementId": "dose_30mg",
        "text": "Following the Run-in Period, participants will be administered ALXN1840 at 15 mg/day for a treatment period of approximately 28 days followed by titration up to 30 mg/day on Day 29."
      },
      {
        "id": "trans_2",
        "name": "Dose Interruption for ALT/AST",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "If ALT and/or AST > 3 × ULN and ≤ 5 × ULN, temporarily interrupt dosing."
      },
      {
        "id": "trans_3",
        "name": "Definitive Discontinuation for ALT/AST",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "If ALT and/or AST > 5 × ULN, definitively discontinue dosing."
      },
      {
        "id": "trans_4",
        "name": "Dose Interruption for Neutropenia",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "If Neutrophils < 1.0 × 10^9/L, temporarily interrupt dosing."
      },
      {
        "id": "trans_5",
        "name": "Dose Reduction for Neutrophil Decrease",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "If Neutrophils > 30% decrease from baseline and below reference range, reduce dose to previous dose level or 15 mg QOD."
      },
      {
        "id": "trans_6",
        "name": "Intervention Discontinuation for Pregnancy",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Participants must be considered for discontinuation from study intervention if... Pregnancy or planned pregnancy... occur during the study."
      },
      {
        "id": "trans_7",
        "name": "Intervention Discontinuation for Hypersensitivity",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Participants must be considered for discontinuation from study intervention if... Serious hypersensitivity reaction... occur during the study."
      },
      {
        "id": "trans_8",
        "name": "Intervention Discontinuation for Infection",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Participants must be considered for discontinuation from study intervention if... Severe uncontrolled infection... occur during the study."
      },
      {
        "id": "trans_9",
        "name": "Intervention Discontinuation for Disallowed Medication",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Participants must be considered for discontinuation from study intervention if... Use of disallowed medication... occur during the study."
      }
    ],
    "scheduleTimelineExits": [
      {
        "id": "exit_1",
        "name": "Study Completion",
        "exitType": "Completion",
        "instanceType": "ScheduleTimelineExit",
        "description": "A participant is considered to have completed the study if he/she has completed all phases of the study including the last scheduled procedure shown in the Schedule of Activities (SoA)."
      },
      {
        "id": "exit_2",
        "name": "Participant Withdrawal",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "A participant may withdraw from the study at any time at his/her own request."
      },
      {
        "id": "exit_3",
        "name": "Investigator Discretionary Withdrawal",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "A participant... may be withdrawn at any time at the discretion of the Investigator for safety, behavioral, compliance, or administrative reasons."
      },
      {
        "id": "exit_4",
        "name": "Lost to Follow-up",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "A participant will be considered lost to follow-up if he or she repeatedly fails to return for scheduled visits and is unable to be contacted by the study site."
      },
      {
        "id": "exit_5",
        "name": "Site Closure",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Alexion reserves the right to close the study site or terminate the study at any time for any reason at the sole discretion of Alexion."
      }
    ],
    "scheduledDecisionInstances": [
      {
        "id": "dec_1",
        "name": "Dose Titration Decision",
        "timepointId": "Day 29",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision point to titrate dose from 15 mg/day to 30 mg/day, contingent on SRC safety review of data through Day 23.",
        "conditionIds": [
          "cond_8"
        ]
      },
      {
        "id": "dec_2",
        "name": "Dose Modification for Safety",
        "timepointId": "Ongoing",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Ongoing decision-making based on safety monitoring (liver function, blood counts, neurologic/psychiatric assessments) to determine if dose modification is required.",
        "conditionIds": [
          "cond_1",
          "cond_2",
          "cond_3",
          "cond_4",
          "cond_5",
          "cond_6",
          "cond_7"
        ]
      },
      {
        "id": "dec_3",
        "name": "Outpatient Period Extension Decision",
        "timepointId": "End of Inpatient Period 1",
        "instanceType": "ScheduledDecisionInstance",
        "description": "At the discretion of the Investigator, the Outpatient Period may be extended by up to 14 days."
      }
    ],
    "summary": {
      "timingCount": 13,
      "conditionCount": 9,
      "transitionRuleCount": 9,
      "exitCount": 5
    }
  }
}